Baxion
Screening
Tags
Alerts
Theme
Alnylam Pharmaceuticals, Inc.
ALNY
·
NASDAQ
·
$295.50
Share Price as of 11/2
·
$39B
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q3 ended 09/30/26
10/29/26
10-Q
Q2 ended 06/30/26
07/30/26
10-Q
Q1 ended 03/31/26
04/30/26
10-K
FY 2025
02/12/26
10-Q
Q3 ended 09/30/25
10/30/25
Disclosures
Filter
8-K
Current report
10/29/26
8-K
Current report
07/30/26
8-K
Current report
05/27/26
8-K
Current report
04/30/26
8-K
Current report
03/04/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
02/12/26
S-8
Registration of securities for employees
02/23/23
S-8
Registration of securities for employees
02/11/21
S-3ASR
Automatic shelf registration
06/05/20
S-8
Registration of securities for employees
02/13/20
Proxies
Filter
DEF 14A
Definitive proxy
04/06/26
DEFA14A
Additional proxy materials
04/06/26
DEFA14A
Additional proxy materials
04/04/25
DEF 14A
Definitive proxy
03/24/25
DEFA14A
Additional proxy materials
03/24/25
Ownership
Filter
Form 4
Insider transaction
10/06/26
144
Proposed sale of securities
10/02/26
Form 4
Insider transaction
09/22/26
Form 3
Initial insider ownership
06/03/26
Form 4
Insider transaction
06/03/26
Other
Filter
ARS
Annual report to shareholders
04/06/26
UPLOAD
Letter from the SEC
06/17/25
CORRESP
Correspondence with the SEC
05/22/25
UPLOAD
Letter from the SEC
05/09/25
ARS
Annual report to shareholders
03/24/25
Latest Filings
Filter
10-Q
Q3 ended 09/30/26
10/29/26
8-K
Current report
10/29/26
10-Q
Q2 ended 06/30/26
07/30/26
8-K
Current report
07/30/26
8-K
Current report
05/27/26
Ownership
Filter
Form 4
Insider transaction
10/06/26
144
Proposed sale of securities
10/02/26
Form 4
Insider transaction
09/22/26
Form 3
Initial insider ownership
06/03/26
Form 4
Insider transaction
06/03/26